Chondroplasty Market Poised for 5.9 % Growth, Set to Hit $18.43 Billion by 2029

Which drivers are expected to have the greatest impact on the over the chondroplasty market's growth?
The rise in cases of joint-related ailments is predicted to fuel chondroplasty market growth. Joint disorders, which are diseases that disrupt the health and functionality of a joint, largely arise from overworking a joint or unexpected injuries such as accidents or sports injuries. Chondroplasty can treat such disorders by mending the damaged cartilage. An example is seen in August 2023, where data from The Lancet demonstrated an increase in gout diagnoses in the UK, with the number surging from 1.40 per 1,000 adults in March 2021 to 1.44 per 1,000 adults in March 2022. As such, the increasing number of joint-related disorders is fuelling the chondroplasty market's growth. The rising tendency towards knee surgical procedures is another factor driving the chondroplasty market's expansion. Knee surgeries are intended to deal with numerous conditions, injuries, or disorders impacting the knee, and chondroplasty plays a significant role in correcting and reshaping the damaged cartilage in a joint, most notably the knee. To elaborate, in February 2022, the National Library of Medicine stated that 2.4 million hip and knee surgeries were conducted at over 1150 facilities, reflecting an 18.3% rise in total procedures compared to 2020. Furthermore, in January 2023, it predicted total knee arthroplasty (TKA) to surge by 139% by 2040 and 469% by 2060. Consequently, the surge in knee surgeries is boosting the growth of the chondroplasty market.

Get Your Chondroplasty Market Report Here:
https://www.thebusinessresearchcompany.com/report/chondroplasty-global-market-report

What is the future CAGR of the chondroplasty market, and how will it impact industry expansion?
In recent times, the chondroplasty market has seen significant growth. The market value, which stands at $13.77 billion in 2024, is projected to reach $14.68 billion in 2025, representing a compound annual growth rate (CAGR) of 6.5%. Several factors such as a high prevalence of sports-related injuries, patient inclination towards non-total joint replacement, advancements in postoperative care, improvement in healthcare provider skills and knowledge, as well as the rising incidence of joint disorders, have contributed to the expansion in the preceding period.

Over the coming years, the chondroplasty market is projected to exhibit robust growth. By 2029, this market is anticipated to reach $18.43 billion, growing at a compound annual growth rate (CAGR) of 5.9%. Factors attributed to this growth during the forecast period include the incorporation of regenerative medicine, a focus on outpatient procedures, new biomaterials, an increase in musculoskeletal disorders, and the expansion of the elderly population. In the forecast period, major trends encompassing technological inclusion in rehabilitation, arthroscopic procedures, cartilage repair and regeneration, innovations in surgical instrument technology, and the integration of navigational systems can be witnessed.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp

How are the latest trends influencing the growth of the chondroplasty market?
Leading enterprises in the chondroplasty market are making strides in creating autologous chondrocytes to improve cartilage restoration. This method uses the patient's own cells, which lowers the risk of immune rejection and encourages natural healing. Autologous chondrocytes represent cartilage cells derived from the patient's body, usually extracted from a joint area that doesn't bear weight. For example, Vericel Corporation, a biopharmaceutical business based in the US, gained FDA approval in August 2024 and began commercial production of MACI Arthro (Matrix Autologous Chondrocyte Implantation). This product presents a major breakthrough in treating knee cartilage defects. MACI Arthro empowers orthopedic surgeons to execute the procedure via small incisions using specially designed tools, which is less aggressive than conventional methods. This technique is anticipated to boost patient recovery times and minimize post-surgery complications.

Which key market segments comprise the chondroplasty market and drive its revenue growth?
The chondroplasty market covered in this report is segmented -

1) By Type: Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, Other Types
2) By Anatomy: Knee, Shoulder, Hip, Other Anatomies
3) By Equipment: Shavers, Radiofrequency Devices, Arthroscope, Other Equipments
4) By End Use: Hospitals, Orthopedic Clinics, Academic Research, Other End Uses

Subsegments:
1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation, Low-Frequency Ablation
2) By Abrasion Chondroplasty: Mechanical Abrasion, Arthroscopic Abrasion
3) By Patellar Chondroplasty: Open Patellar Chondroplasty, Arthroscopic Patellar Chondroplasty
4) By Meniscal Repair: Suturing Techniques, Meniscal Allograft Transplantation
5) By Tissue Removal: Arthroscopic Debridement, Open Debridement
6) By Other Types: Microfracture Techniques, Osteochondral Autograft Transplantation

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13185

What regions are at the forefront of chondroplasty market expansion?
North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the chondroplasty market?
Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp

What Is Covered In The Chondroplasty Global Market Report?

• Market Size Forecast: Examine the chondroplasty market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the chondroplasty market for a structured understanding.
• Key Players Overview: Analyze major players in the chondroplasty market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the chondroplasty market.
• Segment Contributions: Evaluate how different segments drive overall growth in the chondroplasty market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the chondroplasty market.
• Industry Challenges: Identify potential risks and obstacles affecting the chondroplasty market.
• Competitive Landscape: Review strategic developments in the chondroplasty market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.